GS-441524 is a nucleoside analog antiviral drug. It is a prodrug of the active antiviral compound known as GS-443902. GS-441524 is closely related to Remdesivir, which gained attention during the COVID-19 pandemic as a potential treatment for SARS-CoV-2, the virus that causes COVID-19.
GS-441524 and GS-443902 were initially developed by Gilead Sciences for the treatment of RNA virus infections. These compounds work by inhibiting the viral RNA-dependent RNA polymerase, which is crucial for the replication of certain RNA viruses.
One of the notable applications of GS-441524 has been in veterinary medicine, particularly in the treatment of feline infectious peritonitis (FIP). FIP is caused by a coronavirus in cats, and GS-441524 has shown promise in inhibiting the replication of this virus.
Parameter | Value |
---|---|
Specification | 20mg/mL, 30mg/mL |
Product Shelf Life | 1 Year |
Product Form | Injections |
Product Packaging | 10 Vial Per Box |
Shipping Method | Air(UPS, FedEx, TNT, EMS) Or Sea |
Product Usage | Cat FIPV Treatment |
Product Type | Liquid |
Test Method | HPLC UV |
Molecular Weight | C12H13N5O4 |
Product Storage | Store In A Cool, Dry Place |
Product Name | GS441 FIP Treatment |
Packing: 1 box * 10 vials
Recommended treatment: 12 weeks.
Recommended dosage:*DOSAGE IS BASED ON THE WEIGHT AND SYMPTOMS*
Ascites / pleural effusion: 0.5mL/kg * body weight kg + 0.1 residue
FIP(Wet):0.4mL/kg * body weight kg + 0.1 residue
FIP(Dry): 0.6mL/kg * body weight kg + 0.1 residue
Eye / nerve entry: 0.7mL/kg * body weight kg + 0.1 residue
Recurrence: 0.9 mL/ kg * body weight kg + 0.1 residue
Storage
Store at room temperature or Store at 2~4 ° C (Better). Avoid light. Shelf life is one year.
Do not place in a sub-zero environment. Because this will result in the precipitation of active ingredients and the appearance of crystals, thus affecting the concentration and therapeutic effect.